Exenatide ER-induced eosinophilia

Am J Health Syst Pharm. 2020 Jun 23;77(13):1006-1007. doi: 10.1093/ajhp/zxaa105.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / adverse effects
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Eosinophilia / chemically induced*
  • Eosinophilia / diagnosis
  • Exenatide / administration & dosage
  • Exenatide / adverse effects*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Middle Aged

Substances

  • Delayed-Action Preparations
  • Hypoglycemic Agents
  • Exenatide